Min Yang Selected Research

oligo(thiophene-ethynylene)

9/2021

CO/light dual-activatable Ru(ii)-conjugated oligomer agent for lysosome-targeted multimodal cancer therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Yang Research Topics

Disease

241	Neoplasms (Cancer) 11/2022 - 03/2002
72	Inflammation (Inflammations) 03/2022 - 09/2005
65	Infections 08/2022 - 10/2004
37	Fibrosis (Cirrhosis) 01/2022 - 04/2004
28	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2008
26	Rheumatoid Arthritis 12/2021 - 07/2007
21	Carcinogenesis 01/2022 - 04/2005
19	Lung Neoplasms (Lung Cancer) 11/2022 - 04/2011
19	Pain (Aches) 10/2022 - 09/2007
19	Body Weight (Weight, Body) 01/2022 - 08/2007
19	Cardiovascular Diseases (Cardiovascular Disease) 04/2021 - 10/2009
18	Necrosis 01/2022 - 01/2007
17	Hypertension (High Blood Pressure) 05/2022 - 06/2008
17	Stomach Neoplasms (Stomach Cancer) 01/2022 - 07/2013
17	Hypoxia (Hypoxemia) 01/2022 - 01/2012
17	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2006
17	Obesity 04/2021 - 12/2008
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 01/2009
15	Osteoporosis 05/2022 - 11/2011
15	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2015
14	Atherosclerosis 01/2022 - 04/2007
14	Reperfusion Injury 01/2020 - 11/2007
13	Ischemia 01/2022 - 11/2007
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2011
13	Sepsis (Septicemia) 01/2022 - 02/2008
13	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 02/2010
13	Asthma (Bronchial Asthma) 08/2021 - 11/2009
12	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
12	Carcinoma (Carcinomatosis) 01/2022 - 03/2006
12	Multiple Myeloma 01/2022 - 10/2008
12	Myocardial Infarction 12/2021 - 10/2009
12	Arthritis (Polyarthritis) 10/2021 - 05/2011
11	Insulin Resistance 01/2022 - 07/2009
11	Wounds and Injuries (Trauma) 01/2022 - 04/2011
11	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 08/2010
11	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 02/2015
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2008
11	Virus Diseases (Viral Diseases) 01/2021 - 06/2004
11	Heart Arrest (Cardiac Arrest) 04/2020 - 01/2013
10	Tuberculosis (Tuberculoses) 05/2022 - 11/2004
10	Colonic Neoplasms (Colon Cancer) 01/2022 - 12/2013
10	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2016
10	Diarrhea 03/2020 - 09/2012
9	Pneumonia (Pneumonitis) 08/2022 - 01/2015
9	Hemorrhage 04/2022 - 10/2010
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022 - 05/2011
9	Chronic Renal Insufficiency 01/2022 - 01/2014
9	Melanoma (Melanoma, Malignant) 01/2022 - 01/2007
9	Heart Failure 09/2021 - 11/2003
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2021 - 10/2014
9	Diabetes Mellitus 01/2020 - 11/2004
9	Leukemia 01/2017 - 01/2009
8	Colitis 01/2022 - 08/2008

Drug/Important Bio-Agent (IBA)

90	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2002
54	Biomarkers (Surrogate Marker)IBA 08/2022 - 03/2011
44	Pharmaceutical PreparationsIBA 11/2022 - 05/2007
36	CytokinesIBA 09/2021 - 01/2007
27	Biological ProductsIBA 11/2022 - 03/2009
25	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2004
24	Messenger RNA (mRNA)IBA 12/2021 - 01/2002
23	Peptides (Polypeptides)IBA 01/2022 - 06/2004
22	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2003
19	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2012
18	Therapeutic UsesIBA 03/2022 - 07/2009
18	Interleukin-6 (Interleukin 6)IBA 04/2021 - 06/2007
18	EnzymesIBA 01/2021 - 11/2007
16	Long Noncoding RNAIBA 01/2022 - 07/2016
14	CreatinineIBA 01/2021 - 10/2013
13	Antiviral Agents (Antivirals)IBA 03/2022 - 01/2003
13	LigandsIBA 01/2022 - 03/2012
13	AcidsIBA 01/2022 - 04/2008
13	LipidsIBA 03/2020 - 08/2013
13	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 06/2007
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 06/2007
11	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2018
11	C-Reactive ProteinIBA 08/2022 - 01/2011
11	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2003
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 03/2006
10	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2009
10	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2003
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2008
10	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 12/2004
10	InterferonsIBA 01/2020 - 01/2003
9	AntigensIBA 02/2022 - 11/2004
9	CateninsIBA 01/2022 - 02/2014
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 05/2008
9	CollagenIBA 01/2022 - 04/2007
9	Phosphotransferases (Kinase)IBA 01/2021 - 11/2010
9	Insulin (Novolin)FDA Link 01/2020 - 03/2006
8	Indicators and Reagents (Reagents)IBA 01/2022 - 05/2011
8	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
8	InflammasomesIBA 12/2021 - 01/2018

Therapy/Procedure

150	Therapeutics 03/2022 - 03/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 05/2007
17	Immunotherapy 11/2022 - 06/2011
15	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2021 - 07/2008
11	Microvascular Decompression Surgery 05/2017 - 12/2010
9	Precision Medicine 01/2022 - 02/2015
9	Aftercare (After-Treatment) 01/2022 - 07/2009
9	Transplantation 10/2020 - 07/2007